Clinical Trials
17
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (17 trials with phase data)β’ Click on a phase to view related trials
Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis
- First Posted Date
- 2011-01-11
- Last Posted Date
- 2012-02-03
- Lead Sponsor
- Agennix
- Target Recruit Count
- 1280
- Registration Number
- NCT01273779
- Locations
- πΊπΈ
University of Alabama - Birmingham, Birmingham, Alabama, United States
πΊπΈProvidence Hospital, Mobile, Alabama, United States
πΊπΈMaricopa Medical Center, Maricopa, Arizona, United States
Safety and Tolerability of RGB-286638 in Patients With Selected, Relapsed or Refractory Hematological Malignancies
- Conditions
- Hematological Malignancies
- First Posted Date
- 2010-07-23
- Last Posted Date
- 2012-08-02
- Lead Sponsor
- Agennix
- Registration Number
- NCT01168882
Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
- First Posted Date
- 2009-03-03
- Last Posted Date
- 2012-03-15
- Lead Sponsor
- Agennix
- Target Recruit Count
- 120
- Registration Number
- NCT00854633
- Locations
- πΊπΈ
Childrens Hospital of Los Angeles, Los Angeles, California, United States
πΊπΈKosair Children's Hospital, Louisville, Kentucky, United States
πΊπΈUniversity of Louisville Hospital, Louisville, Kentucky, United States
Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer
- First Posted Date
- 2008-06-30
- Last Posted Date
- 2012-08-21
- Lead Sponsor
- Agennix
- Target Recruit Count
- 742
- Registration Number
- NCT00707304
- Locations
- πΊπΈ
Desert Oasis Cancer Center, Casa Grande, Arizona, United States
πΊπΈArizona Oncology Associates, Tucson, Arizona, United States
πΊπΈUniversity of Colorado Hospital, Aurora, Colorado, United States
Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer
- First Posted Date
- 2008-06-30
- Last Posted Date
- 2012-03-15
- Lead Sponsor
- Agennix
- Target Recruit Count
- 1100
- Registration Number
- NCT00706862
- Locations
- πΊπΈ
City of Hope, Duarte, California, United States
πΊπΈRush University Medical Center, Chicago, Illinois, United States
πΊπΈMontefiore Medical Center, Bronx, New York, United States
- Prev
- 1
- 2
- 3
- 4
- Next